Visit our virtual lab at ESCV 2019 and learn about the evolution of molecular testing

Siemens Healthineers Forum on COVID-19 TestingLeading the Way to Normalcy

Dates: Wed, Sep 15, 2021 – Fri, Sep 17, 2021
Location: Online
Register Now! 
Please visit our virtual exhibitor area during the course of the congress and join our forum.

Changing COVID-19 testing demands require clinical laboratories to keep up with an increasing number of patients, samples, and variants. Siemens Healthineers provides the flexibility you want for the clinical results you need with innovative, COVID-19 testing solutions.

While at the Siemens Healthineers Forum, explore our COVID-19 testing portfolio, from a highly sensitive RT-PCR test to high throughput or point of care antigen and antibody assays.

Our Products

SARS-CoV-2 Virus rendering

At the Forum on COVID-19 Testing, you will learn how Siemens Healthineers is shaping the future of healthcare, so you can drive better outcomes.

From the lab to the point of care, Siemens Healthineers offers a full portfolio of COVID-19 testing solutions that consistently delivers sensitivity and performance—to get us to what’s next.

Clinicians use diagnostic tests to determine if people have current COVID-19 infections, enabling patient management decisions.
Intended for fast, safe and accurate, high-scale community screening.

Gold standard for accurate and early detection of infection.

Near-patient testing can be used to identify and isolate infected people more quickly.

Rapid antigen testing can help communities get ahead of the spread.

Management and monitoring are critical in determining the full scope of the disease, combating the pandemic, and rebuilding public confidence.

Highly accurate for detection and monitoring of immune response through infection and in vaccination.

Our Booth at ESCV

How can your laboratory deliver more impactful results for the detection and management of COVID-19?

Explore Siemens Healthineers full portfolio of COVID-19 testing solutions that consistently delivers sensitivity and performance—to get us to what’s next on the path to normalcy.

Friday 17 September
9:00-10:00 CET (8:00-9:00 BST)
Plenary hall

Dr. Guido Hennig: Scientific Affairs at Siemens Healthineers

Alexandre Gilles: SARS-CoV-2 detection: from assay design to variant surveillance, R&D Scientist at Fast Track Diagnostics, a Siemens Healthineers company

Dr. Onur Bilenoglu: SARS-CoV-2 variant identification: how to keep up with mutations? R&D Manager at A1 Lifesciences, Istanbul, Turkey

Prof. Zeynep Ceren Karahan: Laboratory experience on SARS-CoV-2 mutation detection. Ankara University School of Medicine, Department of Medical Microbiology & Ankara University School of Medicine, Ibn-i Sina Hospital, Central Microbiology Laboratory